View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Carole Braudeau
  • Carole Braudeau

Credit Morning 10/04/2024

Casino : Partial repayment of Quatrim bond Elis has also approached Unifirst>...

Carole Braudeau
  • Carole Braudeau

Morning Crédit 04/10/2024

Casino : remboursement partiel de l’obligation Quatrim Elis aurait également approché Unifirst>...

Nicolas David
  • Nicolas David

ODDO : Iberian Forum – Day 2

We hosted our 4th ODDO BHF Iberian Forum on the 1st and 2nd of October 2024, virtually. In total, 63 companies were present. In the following note, we provide some initial feedback from the companies on day 2. - >ACS (=): good operating momentum maintained, Abertis and its dividends on the front page - Atresmedia (=): Q3 should be challenging but outlook reiterated - Befesa (=): zinc prices held up well, offsetting the negative impact of maintenance on Q3 volumes - CaixaBank ...

Carole Braudeau
  • Carole Braudeau

Credit Morning 10/02/2024

Europcar Mobility Group: Corporate EBITDA down to -€ 9m for H1 24Saur: S&P has lowered Saur's (HIME) rating to High Yield>...

Carole Braudeau
  • Carole Braudeau

Morning Crédit 02/10/2024

Europcar Mobility Group : EBITDA Corporate de -9 m EUR au S1 24Saur : S&P a abaissé le rating de Saur (HIME) en High Yield>...

Nicolas David
  • Nicolas David

ODDO : Iberian Forum – Day 1

We host our 4th ODDO BHF Iberian Forum on the 1st and 2nd of October 2024 virtually. In total, 63 companies will be presenting. In the following note, we provide some initial feedback of the company on day 1. - >Acciona (=) : Confidence in Non-energy business steady, Acciona Energía stake sparks intense scrutiny - Acciona Energia (=/-) : A trajectory beyond 2024 to be explained at the 9 months results - Acerinox (=/-): Softness persists in Europe and US - Amadeus (=/+): sol...

Research Department
  • Research Department

IBERIAN DAILY 01 OCTOBER (ANÁLISIS BANCO SABADELL)

NEWS SUMMARY: CELLNEX, INDRA, SOLARIA. Political noise and Automobiles continue to add pressure on the Euro STOXX European equity markets dropped, dragged down by the risks of more aggressive taxation to large French companies and by the profit warnings battery in the Automobile sector. In the STOXX 600, Energy and Consumer Goods were the only sectors ending in positive territory whereas Automobiles and Travel&Leisure saw the biggest drops. On the macro side, in Germany, September’s preliminary...

Research Department
  • Research Department

INFORME DIARIO 01 0CTUBRE (ANÁLISIS BANCO SABADELL)

COMPAÑÍAS QUE APARECEN EN EL INFORME: EUROPA: CELLNEX, INDRA, SOLARIA. El ruido geopolítico y los autos siguen presionando al Euro STOXX Caídas en la renta variable europea, lastradas por los riesgos de una tributación más agresiva a las grandes empresas de Francia y por la ola de profit warnings del sector Autos. En el STOXX 600 sólo Energía y R. Básicos se mantuvieron al margen de las caídas mientras que Autos y Viajes&Ocio sufrieron las mayores pérdidas. Por el lado macro, en Alemania la inf...

 PRESS RELEASE

Press Release: Dupixent approved in the US as the first-ever biologic ...

Press Release: Dupixent approved in the US as the first-ever biologic medicine for patients with COPD   Dupixent approved in the US as the first-ever biologic medicine for patients with COPD         Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled COPD and an eosinophilic phenotype Following recent approvals in the EU and China, the US approval is based on two landmark phase 3 studies that showed Dupixent achieved significant reduction in exacerbations, and also showed improvements in lung function and health-related quality of life comp...

 PRESS RELEASE

Communiqué de presse : Dupixent est le premier médicament biologique a...

Communiqué de presse : Dupixent est le premier médicament biologique approuvé aux États-Unis pour le traitement de la BPCO     Dupixent est le premier médicament biologique approuvé aux États-Unis pour le traitement de la BPCO Dupixent est indiqué à environ 300 000 adultes aux États-Unis présentant une BPCO inadéquatement contrôlée et un phénotype éosinophilique.  L’approbation de ce médicament aux États-Unis fait suite à celle de l’Union européenne et de la Chine et repose sur deux études phares de phase III ayant montré que le Dupixent a permis de réduire significativement les exac...

 PRESS RELEASE

Press Release: Dupixent approved in China as the first-ever biologic m...

Press Release: Dupixent approved in China as the first-ever biologic medicine for patients with COPD Dupixent approved in China as the first-ever biologic medicine for patients with COPD Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils, and is based on two landmark phase 3 studies showing Dupixent significantly reduced exacerbations, improved lung function, and also improved health-related quality of lifeCOPD is the most prevalent chronic respiratory disease in China, and is a priority within the government’s Healthy China 2030 public health plan ...

 PRESS RELEASE

Communiqué de presse : Dupixent, premier médicament biologique approuv...

Communiqué de presse : Dupixent, premier médicament biologique approuvé en Chine pour le traitement de la BPCO Dupixent, premier médicament biologique approuvé en Chine pour le traitement de la BPCO Cette approbation fait suite à celle obtenue dans l’Union européenne pour le traitement des adultes atteints de bronchopneumopathie chronique obstructive présentant une augmentation des éosinophiles dans le sang, et repose sur deux études phares de phase III ayant montré que le Dupixent réduit significativement les exacerbations et améliore la fonction respiratoire, ainsi que la qualité de vie ...

Olfa Taamallah ... (+2)
  • Olfa Taamallah
  • Yan Derocles

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 09/26/2024

‘Soft landing’... the term is in vogue and we think it aptly describes the current situation in the energy market. After a period of “excess profits”, the fundamentals are back in favour and prompt us to revise down our estimates for energy prices. - Alongside renewable energies, pockets of sustainable value creation are emerging for players capable of capitalising on the structural growth in volatility on the electricity markets but which are nonetheless trading at a discount In the U...

Olfa Taamallah ... (+2)
  • Olfa Taamallah
  • Yan Derocles

ODDO BHF Small & MIDCAP MORNING NEWS - 09/26/2024

tonies is a pioneer in the children’s audio entertainment and educational industry, offering a screen-free and interactive listening experience (stories and music) through its Toniebox and Tonies figurines. With a proven track record of rapid international growth, portfolio expansion and strong brand recognition mainly in the DACH region (Germany, Austria and Switzerland) and North America, we see in the coming years: 1/ further strong revenue increases (CAGR 2024-2026e of 25%) with a...

Olfa Taamallah ... (+2)
  • Olfa Taamallah
  • Yan Derocles

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 26/09/2024

“Soft landing”… le terme est à la mode et nous pensons qu’il caractérise bien la situation du marché de l’énergie aujourd’hui. Après une parenthèse de « surprofits », les fondamentaux reprennent leur droit et nous conduisent à réviser en baisse nos hypothèses de prix de l’énergie. A côté du renouvelable, des poches pérennes de création de valeur apparaissent pour les acteurs capables de profiter de la croissance structurelle de la volatilité des marchés électriques et qui souffrent ma...

Olfa Taamallah ... (+2)
  • Olfa Taamallah
  • Yan Derocles

ODDO BHF Small & MIDCAP MORNING NEWS - 26/09/2024

tonies is a pioneer in the children’s audio entertainment and educational industry, offering a screen-free and interactive listening experience (stories and music) through its Toniebox and Tonies figurines. With a proven track record of rapid international growth, portfolio expansion and strong brand recognition mainly in the DACH region (Germany, Austria and Switzerland) and North America, we see in the coming years: 1/ further strong revenue increases (CAGR 2024-2026e of 25%) with a...

Konrad Zomer ... (+2)
  • Konrad Zomer
  • Stephane Beyazian

ODDO : More users switching provider in France, Italy and the UK

>More consumers are looking to change provider in France, Italy and UK - The Oliver Wyman consultancy published yesterday a survey with 7,000 consumers in five countries (see page 2). These studies are not indisputable but offer additional indicators.Mobile market: according to the survey, the desire to switch operator within 24 months is up sharply in Italy (27%, +9pp), the UK (31%, +6pp) and France (27%, +4pp). No major shifts in Germany (26%, +2pp) or Spain (2...

Konrad Zomer ... (+2)
  • Konrad Zomer
  • Stephane Beyazian

ODDO : Plus d’envies de résiliations en France, Italie et au Royaume-U...

>Les consommateurs veulent plus bouger en France, Italie et Royaume-Uni - La cabinet Oliver Wyman a publié hier un sondage auprès de 7 000 consommateurs dans 5 pays (Cf. page 2). Ces études ne sont pas incontestables mais offrent des indicateurs de plus.Marché mobile : selon l’étude, la volonté de changer d’opérateur d’ici 24 mois est en nette hausse en Italie (27%, +9pp), au R-U (31%, +6pp) et en France (27%, +4pp). Pas de grand changement en Allemagne (26%, +2p...

 PRESS RELEASE

Press Release: Availability of the Q3 2024 Aide mémoire

Press Release: Availability of the Q3 2024 Aide mémoire Availability of the Q3 2024 Aide mémoire Paris, France – September 26, 2024. Sanofi announced today that its Q3 2024 Aide mémoire is available on the "Investors" page of the company's website: As for each quarter, Sanofi prepared this document to assist in the financial modelling of the Group's quarterly results. This document includes a reminder on various non-comparable items and exclusivity losses as well as the foreign currency impact and share count. Sanofi's third-quarter 2024 results will be published on October 25, 2024. A...

 PRESS RELEASE

Communiqué de presse : Mise en ligne du document «Q3 2024 Aide mémoire...

Communiqué de presse : Mise en ligne du document «Q3 2024 Aide mémoire » Mise en ligne du document «Q3 2024 Aide mémoire » Paris, France, le 26 Septembre 2024. Sanofi annonce la mise en ligne sur l'espace Investisseurs du site internet de la société, d'un document intitulé « Q3 2024 Aide mémoire ». Comme chaque trimestre, ce document vise à assister la communauté financière dans la modélisation des résultats trimestriels de la Société. Ce document contient un rappel de divers éléments non récurrents et de pertes d’exclusivité, l’effet des variations monétaires et le nombre d’actions. Le...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch